Showing results (21-30 of 175) with videos related to
Sort By:
Pageof 18
Hematology/Oncology Clinics of North America|March 1, 2021
Quality of Life in Myeloproliferative Neoplasms: Symptoms and Management ImplicationsRuben Mesa, Jeanne Palmer, Ryan Eckert, et al.Blood Advances|April 29, 2020
Fedratinib in myelofibrosisAnn Mullally, John Hood, Claire Harrison, et al.Cancer|September 28, 2023
Top advances of the year: Myeloproliferative neoplasmsRupali R Bhave, Ruben Mesa, Michael R GrunwaldRare Tumors|April 26, 2012
Asian-variant intravascular lymphoma in the African raceHolly Geyer, Nina Karlin, Brian Palen, et al.British Journal of Haematology|April 3, 2012
Janus kinase inhibition and its effect upon the therapeutic landscape for myelofibrosis: from palliation to cure?Claire Harrison, Srdan Verstovsek, Mary F McMullin, et al.Leukemia & Lymphoma|June 18, 2013
Epidemiology of myeloproliferative neoplasms in the United StatesJyotsna Mehta, Hongwei Wang, Sheikh Usman Iqbal, et al.Current Hematologic Malignancy Reports|September 29, 2015
Social Media and Myeloproliferative Neoplasms (MPN)--Focus on Twitter and the Development of a Disease-specific Community: #MPNSMNaveen Pemmaraju, Vikas Gupta, Ruben Mesa, et al.Integrative Cancer Therapies|July 27, 2016
Physical Activity as a Nonpharmacological Symptom Management Approach in Myeloproliferative Neoplasms: Recommendations for Future ResearchRyan Eckert, Jennifer Huberty, Krisstina Gowin, et al.JMIR Cancer|July 24, 2019
Experiences of Using a Consumer-Based Mobile Meditation App to Improve Fatigue in Myeloproliferative Patients: Qualitative StudyJennifer Huberty, Ryan Eckert, Linda Larkey, et al.Annals of Hematology|January 30, 2019
Relationship between symptom burden and disability leave among patients with myeloproliferative neoplasms (MPNs): findings from the Living with MPN patient surveyJingbo Yu, Dilan Paranagama, Holly L Geyer, et al.Pageof 18